Kinnate Biopharma is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. It utilizes its expertise in structure-based drug discovery, translational research, and patient-driven precision medicine, which the company refers to as the Kinnate Discovery Engine, to develop targeted therapies.
|HQ||San Diego, CA, US||Map|
Net income (FY, 2019)
EBIT (FY, 2019)
Market capitalization (16-Jun-2021)
Closing stock price (16-Jun-2021)
When was Kinnate Biopharma founded?
Kinnate Biopharma was founded in 2018.
Who are Kinnate Biopharma key executives?
Kinnate Biopharma's key executives are Nima Farzan, Eric Murphy and Mark Meltz.
How many employees does Kinnate Biopharma have?
Kinnate Biopharma has 27 employees.
Who are Kinnate Biopharma competitors?
Competitors of Kinnate Biopharma include Shorla Pharma, Felicitex Therapeutics and XNK Therapeutics.
Where is Kinnate Biopharma headquarters?
Kinnate Biopharma headquarters is located at 11975 El Camino Real #101, San Diego.
Where are Kinnate Biopharma offices?
Kinnate Biopharma has an office in San Diego.
How many offices does Kinnate Biopharma have?
Kinnate Biopharma has 1 office.
Receive alerts for 300+ data fields across thousands of companies